News | Robotic Systems | May 28, 2019

Corindus CorPath GRX Used in Live Complex Robotic-Assisted Coronary Intervention at EuroPCR 2019

Case broadcast live to thousands of EuroPCR attendees from Clinique Pasteur in France

Corindus CorPath GRX Used in Live Complex Robotic-Assisted Coronary Intervention at EuroPCR 2019

May 28, 2019 — Corindus Vascular Robotics Inc. announced its CorPath GRX System was successfully used to perform a live complex robotic-assisted percutaneous coronary intervention (PCI) at the EuroPCR 2019 Conference, May 21-24 in Paris, France.

Jean Fajadet, M.D., Interventional cardiologist, PCR vice-chairman and course director of EuroPCR, performed the procedure from Clinique Pasteur in Toulouse, France. It was broadcast live to EuroPCR attendees, marking the first time a robotic procedure using CorPath GRX was performed and broadcast live in Europe. Fajadet is the co-director of the interventional cardiology unit at Clinique Pasteur, which became the first site in Europe to adopt Corindus’ most advanced vascular robotic technology when it installed the CorPath GRX System this year.

The CorPath System is the world’s only U.S. Food and Drug Administration (FDA)-cleared and CE marked robotic platform for percutaneous coronary intervention (PCI) and peripheral vascular intervention (PVI) procedures, according to the company. CorPath GRX received CE mark for neurovascular intervention in April 2019, broadening the application of the CorPath GRX System to treat all vascular beds in Europe.

“CorPath GRX offers the level of precision and control necessary to perform even the most complex PCI procedures,” said Fajadet. “The live case went exactly as planned. I was able to complete the procedure with control of all interventional devices and imaging equipment from the control room, providing my patient with high-quality care while protecting myself and the cath lab team. I am pleased to share this technology with my peers to demonstrate how far it has come, and the promising future it may provide patients.”

For more information: www.corindus.com


Related Content

News | Robotic Systems

June 11, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, today ...

Home June 11, 2024
Home
News | Robotic Systems

June 6, 2024 — A new, robotic approach to heart bypass surgery is now being offered to patients at University Hospitals ...

Home June 06, 2024
Home
News | Robotic Systems

March 18, 2024 — SS Innovations International, Inc., a developer of innovative surgical robotic technologies dedicated ...

Home March 18, 2024
Home
News | Robotic Systems

March 12, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home March 12, 2024
Home
News | Robotic Systems

January 8, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention ...

Home January 08, 2024
Home
News | Robotic Systems

December 27, 2023 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, and ...

Home December 27, 2023
Home
News | Robotic Systems

November 7, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home November 07, 2023
Home
News | Robotic Systems

July 19, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home July 19, 2023
Home
News | Robotic Systems

May 24, 2023 — Stereotaxis announced a global collaboration with Abbott to integrate Abbott’s EnSite X EP System with ...

Home May 24, 2023
Home
News | Robotic Systems

May 17, 2023 — Robocath, a company that designs, develops and commercializes smart robotic solutions for the treatment ...

Home May 17, 2023
Home
Subscribe Now